GRAIL, Inc.
Company Information
Industry
Services-Medical Laboratories
SIC Code
8071
Entity Type
operating
SEC Category
Non-accelerated filerSmaller reporting companyEmerging growth company
State of Incorporation
DE
Business Address
1525 O'BRIEN DRIVE, MENLO PARK, CA, 94025
Mailing Address
1525 O'BRIEN DRIVE, MENLO PARK, CA, 94025
Phone
(833) 694-2553
Fiscal Year End
1231
EIN
863673636
Financial Overview
FY2025
$2.98B
Total Assets
$249.73M
Cash & Equivalents
Recent SEC Filings
| Form Type | Date Filed | Document |
|---|---|---|
| SCHEDULE 13G/A Passive ownership amendment | March 27, 2026 | View on SEC |
| 10-K Annual financial report | March 12, 2026 | View on SEC |
| 4 Insider stock transaction report | March 9, 2026 | View on SEC |
| 4 Insider stock transaction report | March 9, 2026 | View on SEC |
| 4 Insider stock transaction report | March 9, 2026 | View on SEC |
| 4 Insider stock transaction report | March 3, 2026 | View on SEC |
| 4 Insider stock transaction report | March 3, 2026 | View on SEC |
| 4 Insider stock transaction report | March 3, 2026 | View on SEC |
| 8-K Current report of material events | February 19, 2026 | View on SEC |
| SCHEDULE 13G/A Passive ownership amendment | February 17, 2026 | View on SEC |
Annual Reports
10-K
March 12, 2026
- Robust 25% revenue growth in 2025, reaching $200 million, driven by both screening and developmental services.
- Pioneering multi-cancer early detection (MCED) technology with Galleri, addressing a dynamic and growing market.
Insider Trading
STRONG SELL
3 insiders
21 recent transactions
View Full Insider Trading Profile
Related Companies
Companies in the same industry (SIC: 8071)
Investor Resources
Learn more about SEC filings and how to research public companies.
What is the SEC?
A plain English guide to the Securities and Exchange Commission
Understanding SEC Filings & CIK
How to navigate SEC filings and Central Index Keys
10-K Annual Reports Explained
Everything you need to know about annual reports
S-1 & F-1 IPO Filings
Understanding IPO registration statements
SEC EDGAR Database Guide
How to use the SEC's free filing database
Important Disclaimer
This AI-generated analysis is for informational purposes only and does not constitute financial or investment advice. Always consult with qualified professionals and conduct your own research before making investment decisions.